Danaher Corporation (DHR) : 15 analysts are covering Danaher Corporation (DHR) and their average rating on the stock is 1.7, which is read as a Buy. 9 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Danaher Corporation (DHR) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 5, which recommends a Strong Sell affirms that they expect a large upside in the stock from the current levels. A total of 5 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.
Danaher Corporation (DHR) has been rated by 13 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $120 and the lowest price target forecast is $82. The average forecast of all the analysts is $94.15 and the expected standard deviation is $9.65.
For the current week, the company shares have a recommendation consensus of Buy. Danaher Corporation (NYSE:DHR): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $81.29 and $81.25 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $81.76. The buying momentum continued till the end and the stock did not give up its gains. It closed at $81.54, notching a gain of 0.39% for the day. The total traded volume was 1,649,104 . The stock had closed at $81.22 on the previous day.
In a related news, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the director officer (President and CEO) of Danaher Corp /De/, Joyce Thomas Patrick Jr had sold 45,897 shares worth of $3,737,852 in a transaction dated August 1, 2016. In this transaction, 45,897 shares were sold at $81.44 per share.
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. The Test & Measurement segment offers test, measurement and monitoring products. The Environmental segment products and services help protect the global water supply, facilitate environmental stewardship and enhance the safety of personal data. The Companys diagnostics business offers analytical instruments, reagents, consumables, software and services. The Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Companys Industrial Technologies solutions help protect the worlds food supply, improve packaging design and quality, verify pharmaceutical dosages and authenticity and power innovative machines.